Cargando…
Small Molecule Inhibitors of the Response Regulator ArsR Exhibit Bactericidal Activity against Helicobacter pylori
Helicobacter pylori is considered the most prevalent bacterial pathogen in humans. The increasing antibiotic resistance evolved by this microorganism has raised alarm bells worldwide due to the significant reduction in the eradication rates of traditional standard therapies. A major challenge in thi...
Autores principales: | González, Andrés, Casado, Javier, Chueca, Eduardo, Salillas, Sandra, Velázquez-Campoy, Adrián, Sancho, Javier, Lanas, Ángel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232201/ https://www.ncbi.nlm.nih.gov/pubmed/32244717 http://dx.doi.org/10.3390/microorganisms8040503 |
Ejemplares similares
-
Repurposing Dihydropyridines for Treatment of Helicobacter pylori Infection
por: González, Andrés, et al.
Publicado: (2019) -
Identifying potential novel drugs against Helicobacter pylori by targeting the essential response regulator HsrA
por: González, Andrés, et al.
Publicado: (2019) -
ArsRS-Dependent Regulation of homB Contributes to Helicobacter pylori Biofilm Formation
por: Servetas, Stephanie L., et al.
Publicado: (2018) -
Flavodoxins as Novel Therapeutic Targets against Helicobacter pylori and Other Gastric Pathogens
por: Salillas, Sandra, et al.
Publicado: (2020) -
1,4-Dihydropyridine as a Promising Scaffold for Novel Antimicrobials Against Helicobacter pylori
por: González, Andrés, et al.
Publicado: (2022)